Concepedia

Terrence Bradley

TB

21

Publications

903

Citations

14

H-Index

2018

Active since

Affiliations

Sylvester Comprehensive Cancer Center(Current)

University of Miami

The University of Texas MD Anderson Cancer Center

University of Oxford

Moffitt Cancer Center

Terrence Bradley is an author at Sylvester Comprehensive Cancer Center specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

2018–2024

21

Publications

21

Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Naval Daver, Alexander E. Perl, Joseph Maly et al. · Journal of Clinical Oncology · 2022 · 179 citations · Full text

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study

David A. Sallman, Monzr M. Al Malki, Adam S. Asch et al. · Journal of Clinical Oncology · 2023 · 148 citations · Full text

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results

Naval Daver, Paresh Vyas, Suman Kambhampati et al. · Journal of Clinical Oncology · 2023 · 110 citations · Full text

Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients: Phase Ib results.

David A. Sallman, Monzr Al Malki, Adam S. Asch et al. · Journal of Clinical Oncology · 2020 · 81 citations

, , +16

Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results.

Naval Daver, Paresh Vyas, Suman Kambhampati et al. · Journal of Clinical Oncology · 2022 · 47 citations

, , +14

Rows per page

1–5 of 21